Welcome

Enabling drug release from medical devices

PolyActiva Pty Ltd uses a unique drug-polymer conjugate technology to enable site specific drug delivery from medical device components, such as implants, films, or fibers.

**Press release: PolyActiva completes recruitment in key Phase I glaucoma implant safety study. Six-month treatment period demonstrated…read more…

Products

The PolyActiva product portfolio is composed of market validated products at different stages of development and with different risk / reward profiles.

Glaucoma Program

Treatment of Glaucoma:
High Dose Loadings & Complete Bioerosion

Endophthalmitis Program

Preventive & Treatment Implants:
Sustained Drug Release & Fully Biodegradable

Anti-Inflammatory Program

Intra-articular Injectable Gel & Ocular Implants:
Delivery of NSAIDs

Technology

PolyActiva has developed a platform technology that enables the slow release, site-specific drug delivery directly to the site of action.

Platform

Next generation in drug delivery

Patents

Innovation & Technology designed by PolyActiva

Pipeline

Therapeutic products for ocular diseases and other applications

Our Company

PolyActiva's drug-polymer conjugate technology enables site specific drug delivery from medical devices.

Video

See how the technology works